AKE 0.00% $9.83 allkem limited

Citi rated Sell, Macquarie rated buy, page-4

  1. 724 Posts.
    lightbulb Created with Sketch. 2
    i have MAC's full report ...can not seem to find Citi's full report

    FNArena

    Column 1
    0
    Column 1
    0
    Column 1
    0
    Column 1
    0 Orocobre's Olaroz lithium production ramp-up is meeting rising prices as rapidly growing demand meets supply constraints, the broker notes. Olaroz production is set to double within 12 months and again by 2020 when phase II is completed.
    Orocobre has set further targets with regard future production and processing that rival Tesla's ambitious goals for its electric cars, the broker notes. But challenges notwithstanding, success would unlock significant value.
    Coverage initiated with an Outperform rating and $5.00 target.
    Target price is $5.00 Current Price is $4.30 Difference: $0.7
    [/LEFT][/table][/table][/table]


    FNArena

    Column 1
    0
    Column 1
    0
    Column 1
    0
    Column 1
    0 Citi analysts have now incorporated management's near term price indications for lithium and this has pushed up the share price target to $2.22 from $2.10.
    The analysts remain of the view investors are too bullish on long term price expectations, plus in the words of the analysts, the market is mispricing the risk surrounding the final commissioning stage of the Olaroz project.
    The analysts do not exclude the possibility for even higher prices in the short to medium term, but these are opportunistic and unsustainable, in their opinion. Sell. Orocobre is now anticipated to be profitable in FY17.
    Target price is $2.22 Current Price is $4.30 Difference: minus $2.08 (current price is over target).
    [/LEFT][/table][/table][/table]

    all info from Fnarena.com
 
watchlist Created with Sketch. Add AKE (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.